EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

A Comprehensive Review of Clinically Applied Adeno-Associated Virus-Based Gene Therapies for Ocular Disease

Valerie G Hinsch, Sanford L Boye, Shannon E Boye iD

Human Gene Therapy · 2025-10 · 36 (19-20) · 1301-1320

DOI: 10.1089/hum.2024.252 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Gene Therapy, online erschienen am 08.10.2025. Verfasst von Valerie G Hinsch und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Genetic Therapy, Dependovirus, Genetic Vectors, Eye Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The eye is an ideal target for gene therapy due its accessibility, immune privilege, small size, and compartmentalization. Adeno-associated virus (AAV) is the gold standard vector for gene delivery and can be injected via multiple routes of administration to target different parts of this organ. The approval of Luxturna™, a subretinally delivered gene therapy for RPE65 -associated Leber’s congenital amaurosis, and the large number of successful proof of concept studies performed in animal models injected great momentum into the pursuit of additional AAV-based gene therapies for the treatment of retinal disease. This review provides a comprehensive summary of all subretinally, intravitreally, and suprachoroidally delivered AAV-based ocular gene therapies that have progressed to clinical stage. Attention is given to primary (safety) and secondary (efficacy) outcomes, or lack thereof. Lessons learned and future directions are addressed, both of which point to optimism that the ocular gene therapy field is poised for continued momentum and additional regulatory approvals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyDependovirusGenetic VectorsEye DiseasesHumansAnimalsGene Transfer Techniques

Stichwörter der Autor:innen

AAVclinical trialintravitrealretinasubretinal

Autor:innen und Institutionen

  • Division of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida, Gainesville, Florida, USA.
  • Department of Pediatrics, Powell Gene Therapy Center, University of Florida, Gainesville, Florida, USA.

ORCID-Profile: Shannon E Boye

Förderung

  • NEI NIH HHS

Zitieren

APA

Hinsch, V. G., Boye, S. L., & Boye, S. E. (2025). A Comprehensive Review of Clinically Applied Adeno-Associated Virus-Based Gene Therapies for Ocular Disease. Human Gene Therapy, 36(19-20), 1301-1320. https://doi.org/10.1089/hum.2024.252

Vancouver

Hinsch VG, Boye SL, Boye SE. A Comprehensive Review of Clinically Applied Adeno-Associated Virus-Based Gene Therapies for Ocular Disease. Human Gene Therapy. 2025;36(19-20):1301-1320. doi:10.1089/hum.2024.252

BibTeX
@article{Hinsch2025,
  author = {Hinsch, Valerie G and Boye, Sanford L and Boye, Shannon E},
  title = {A Comprehensive Review of Clinically Applied Adeno-Associated Virus-Based Gene Therapies for Ocular Disease},
  journal = {Human Gene Therapy},
  year = {2025},
  volume = {36},
  number = {19-20},
  pages = {1301--1320},
  doi = {10.1089/hum.2024.252}
}
Kostenlos starten →